Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from liver tissue from rats that had been orally dosed with the drug. The protein-drug complex comprised fatty acid binding protein 1, FABP1, non-covalently bound to the small molecule therapeutic bezafibrate. Moreover, we demonstrate spatial mapping of the [FABP1+bezafibrate] complex across a thin section of liver by targeted mass spectrometry imaging. This work is the first demonstration of in situ mass spectrometry analysis of a non-covalent protein-drug complex formed in vivo and has implications for early stage drug discovery by providing a route to target-drug characterization directly from the physiological environment.
The intact protein–drug complex formed in vivo between endogenous liver fatty acid binding protein (FABP1) and the small molecule therapeutic bezafibrate was detected in ex vivo liver tissue from orally dosed rats by native ambient mass spectrometry. The spatial distribution of the protein–drug complex was imaged by nanospray desorption electrospray ionization.
Keywords: Ex vivo Tissue; Mass Spectrometry Imaging; Native Ambient Mass Spectrometry; Protein–Drug Complex.
© 2022 The Authors. Angewandte Chemie published by Wiley-VCH GmbH.